Fred W. Whitehouse

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Bone Loss and Bone Turnover in Diabetes

Jesse C. Krakauer, Malachi J. McKenna, Nancy Fenn Buderer et al. · Diabetes · 1995 · 475 citations

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

Fred W. Whitehouse, Davida Kruger, Mark Fineman et al. · Diabetes Care · 2002 · 258 citations · Full text

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

Zhuo Chen, Miao Feng, Andrew D. Paterson et al. · Proceedings of the National Academy of Sciences · 2016 · 238 citations · Full text